Skip to main content
SpringerLink
Log in

Malignant Tumors Arising in Inflammatory Bowel Disease

  • Chapter
Pediatric Inflammatory Bowel Disease

  • 803 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7–17.

    Article  PubMed  CAS  Google Scholar 

  2. Itzkowitz SH. Inflammatory bowel disease and cancer. Gastroenterol Clin North Am 1997;26:129–39.

    Article  PubMed  CAS  Google Scholar 

  3. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634–48.

    Article  PubMed  Google Scholar 

  4. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, Burmer GC. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369–78.

    PubMed  CAS  Google Scholar 

  5. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996;56:1237–40.

    PubMed  CAS  Google Scholar 

  6. Suzuki H, Harpaz N, Tarmin L, Yin J, Jiang HY, Bell JD, Hontanosas M, Groisman GM, Abraham JM, Meltzer SJ. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res 1994;54:4841–4.

    PubMed  CAS  Google Scholar 

  7. Crohn BB, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 1925;170:220–228.

    Article  Google Scholar 

  8. Bargen TA. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928;17:862–868.

    Google Scholar 

  9. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17–21.

    Article  PubMed  CAS  Google Scholar 

  10. Bargen JA, Gage RP. Carcinoma and ulcerative colitis:Prognosis. Gastro 1960;39:385–392.

    CAS  Google Scholar 

  11. Slaney G, Brooke BN. Cancer in ulcerative colitis. Lancet 1959;2:694–698.

    Article  PubMed  CAS  Google Scholar 

  12. Rozen P, et al. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology.1995;108:1361–70.

    Article  PubMed  CAS  Google Scholar 

  13. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228–33.

    Article  PubMed  CAS  Google Scholar 

  14. Gilat T, Fireman Z, Grossman A, Hacohen D, Kadish U, Ron E, Rozen P, Lilos P. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel.Gastroenterology 1988;94:870–7.

    PubMed  CAS  Google Scholar 

  15. Leidenius M, Kellokumpu I, Husa A, Riihela M, Sipponen P. Dysplasia and carcinoma in longstanding ulcerative colitis: An endoscopic and histological surveillance programme. Gut 1991;32:1521–5.

    Article  PubMed  CAS  Google Scholar 

  16. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444–51.

    PubMed  CAS  Google Scholar 

  17. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526–35.

    Article  PubMed  CAS  Google Scholar 

  18. Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Long-term risk of cancer in ulcerative colitis: A population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004;2:1088–95.

    Article  PubMed  Google Scholar 

  19. Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population-based study. Inflamm Bowel Dis 2006;12:205–11.

    Article  PubMed  Google Scholar 

  20. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer 2001;91:854–62.

    Article  PubMed  CAS  Google Scholar 

  21. Jess T, Loftus EV, Jr., Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ, 3rd, Munkholm P, Sandborn WJ. Risk of intestinal cancer in inflammatory bowel disease: A population-based study from olmsted county, Minnesota. Gastroenterology 2006;130:1039–46.

    Article  PubMed  Google Scholar 

  22. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030–8.

    Article  PubMed  Google Scholar 

  23. Edwards F, Truelove S. The course and prognosis of ulcerative colitis. III and IV. Gut 1964;5:1.

    Article  PubMed  CAS  Google Scholar 

  24. Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, Lofberg R, Brostrom O, Hellers G. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut 1988;29:206–17.

    Article  PubMed  CAS  Google Scholar 

  25. Greenstein AJ, Sachar DB, Smith H, Pucillo A, Papatestas AE, Kreel I, Geller SA, Janowitz HD, Aufses AH, Jr. Cancer in universal and left-sided ulcerative colitis: Factors determining risk. Gastroenterology 1979;77:290–4.

    PubMed  CAS  Google Scholar 

  26. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: A study on the course and prognostic factors. Scand J Gastroenterol 1996;31:260–6.

    Article  PubMed  CAS  Google Scholar 

  27. Katzka I, Brody RS, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice. Gastroenterology 1983;85:22–9.

    PubMed  CAS  Google Scholar 

  28. Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986;58:1569–74.

    Article  PubMed  CAS  Google Scholar 

  29. Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis 2003;9:351–5.

    Article  PubMed  Google Scholar 

  30. Gurbuz AK, Giardiello FM, Bayless TM. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995;38:37–41.

    Article  PubMed  CAS  Google Scholar 

  31. Loftus EV, Jr., Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ, 3rd. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis [see comments]. Gastroenterology 1996;110:432–40.

    Article  PubMed  Google Scholar 

  32. Nuako KW, Ahlquist DA, Sandborn WJ, Mahoney DW, Siems DM, Zinsmeister AR. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis:A case-control study. Cancer 1998;82:822–6.

    Google Scholar 

  33. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin CE. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996;110:331–8.

    Article  PubMed  CAS  Google Scholar 

  34. Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis–a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992;102:1877–80.

    PubMed  CAS  Google Scholar 

  35. Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis:Evidence for increased neoplastic potential. Hepatology 1995;22:1404–8.

    PubMed  CAS  Google Scholar 

  36. D’Haens GR, Lashner BA, Hanauer SB. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993;88:1174–8.

    PubMed  CAS  Google Scholar 

  37. Marchesa P, Lashner BA, Lavery IC, Milsom J, Hull TL, Strong SA, Church JM, Navarro G, Fazio VW. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997;92:1285–8.

    PubMed  CAS  Google Scholar 

  38. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997;41:522–5.

    Article  PubMed  CAS  Google Scholar 

  39. Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am 1996;25:793–803.

    Article  PubMed  CAS  Google Scholar 

  40. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology 1989;97:255–9.

    PubMed  CAS  Google Scholar 

  41. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997;112:29–32.

    Article  PubMed  CAS  Google Scholar 

  42. Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis:A case-control study. Gastroenterology 1998;115:1079–83.

    Article  PubMed  CAS  Google Scholar 

  43. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, Ekbom A. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356–62.

    Article  PubMed  CAS  Google Scholar 

  44. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis:A case-control study. Aliment Pharmacol Ther 2000;14:145–53.

    Article  PubMed  CAS  Google Scholar 

  45. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126(2):451–9.

    Article  PubMed  Google Scholar 

  46. Bansali R, Itzkowitz S, Harpaz N, Hossein S, Matula S, Bodian C, Ullman T. Severity of Inflammation Predicts Progression to Colorectal Neoplasia in Ulcerative Colitis, In American College of Gastroenterology, Honolulu, HI, 2005.

    Google Scholar 

  47. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study. Gastroenterology 1994;107:117–20.

    PubMed  CAS  Google Scholar 

  48. Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001;134:89–95.

    PubMed  CAS  Google Scholar 

  49. van Staa TP, Card T, Logan RF, Leufkens HG. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: A large epidemiological study. Gut 2005;54:1573–8.

    Article  PubMed  CAS  Google Scholar 

  50. Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:1346–50.

    Article  PubMed  CAS  Google Scholar 

  51. Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98:2784–8.

    Article  PubMed  CAS  Google Scholar 

  52. Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 2007 Apr;13(4):367–71.

    Article  Google Scholar 

  53. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk:A systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005;100:1345–53.

    Article  PubMed  CAS  Google Scholar 

  54. Pardi DS, Loftus EV, Jr., Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124:889–93.

    Article  PubMed  CAS  Google Scholar 

  55. Choi PM, Nugent FW, Schoetz DJ, Jr., Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418–24.

    PubMed  CAS  Google Scholar 

  56. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis [see comments]. Gastroenterology 1994;107:934–44.

    PubMed  CAS  Google Scholar 

  57. Becker JM. Surgical therapy for ulcerative colitis and Crohn disease. Gastroenterol Clin North Am 1999;28:371–90, viii–ix.

    Google Scholar 

  58. Stern H, Walfisch S, Mullen B, McLeod R, Cohen Z. Cancer in an ileoanal reservoir: A new late complication? Gut 1990;31:473–5.

    Article  PubMed  CAS  Google Scholar 

  59. Thompson-Fawcett MW, Marcus V, Redston M, Cohen Z, McLeod RS. Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology 2001;121:275–81.

    Article  PubMed  CAS  Google Scholar 

  60. Morson BC, Pang LS. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423–34.

    Article  PubMed  CAS  Google Scholar 

  61. Cook MG, Goligher JC. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology 1975;68:1127–36.

    PubMed  CAS  Google Scholar 

  62. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985;28:383–8.

    Article  PubMed  CAS  Google Scholar 

  63. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, Spencer MP, Zinsmeister AR. Dysplasia in chronic ulcerative colitis:Implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950–6.

    Article  PubMed  CAS  Google Scholar 

  64. Dickinson RJ, Dixon MF, Axon AT. Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet 1980;2:620–2.

    Article  PubMed  CAS  Google Scholar 

  65. Levin B, Lennard-Jones J, Riddell RH, Sachar D, Winawer SJ. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 1991;69:121–6.

    PubMed  CAS  Google Scholar 

  66. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997;92:204–11.

    PubMed  CAS  Google Scholar 

  67. Brostrom O, Lofberg R, Ost A, Reichard H. Cancer surveillance of patients with longstanding ulcerative colitis: A clinical, endoscopical, and histological study. Gut 1986;27:1408–13.

    Article  PubMed  CAS  Google Scholar 

  68. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy. Gastroenterology 1981;80:366–74.

    PubMed  CAS  Google Scholar 

  69. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989;34:1536–41.

    Article  PubMed  CAS  Google Scholar 

  70. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study. Am J Gastroenterol 1990;85:1083–7.

    PubMed  CAS  Google Scholar 

  71. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: Assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977;73:1280–9.

    PubMed  CAS  Google Scholar 

  72. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years. Gut 1990;31:800–6.

    Article  PubMed  CAS  Google Scholar 

  73. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis–a 15-year follow-up study. Gastroenterology 1990;99:1021–31.

    PubMed  CAS  Google Scholar 

  74. Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075–80.

    Article  PubMed  CAS  Google Scholar 

  75. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241–8.

    PubMed  CAS  Google Scholar 

  76. Rutegard J, Ahsgren L, Stenling R, Janunger KG. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988;23:139–45.

    PubMed  CAS  Google Scholar 

  77. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia. Gastroenterology 1992;103:431–8.

    PubMed  CAS  Google Scholar 

  78. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;125:1311–9.

    Article  PubMed  Google Scholar 

  79. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998;42:711–4.

    Article  PubMed  CAS  Google Scholar 

  80. Velayos FS, Loftus EV, Jr., Jess T, Harmsen WS, Bida J, Zinsmeister AR, Tremaine WJ, Sandborn WJ. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006;130:1941–9.

    Article  PubMed  Google Scholar 

  81. Gage TP. Managing the cancer risk in chronic ulcerative colitis. A decision- analytic approach. J Clin Gastroenterol 1986;8:50–7.

    Article  PubMed  CAS  Google Scholar 

  82. Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut 2000;46:500–6.

    Article  PubMed  CAS  Google Scholar 

  83. Inadomi JM. Cost-effectiveness of colorectal cancer surveillance in ulcerative colitis. Scand J Gastroenterol Suppl 2003:17–21.

    Google Scholar 

  84. Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut 2000;46:500–6.

    Article  PubMed  CAS  Google Scholar 

  85. Provenzale D, Kowdley KV, Arora S, Wong JB. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis [see comments]. Gastroenterology 1995;109:1188–96.

    Article  PubMed  CAS  Google Scholar 

  86. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, et al. Dysplasia in inflammatory bowel disease:Standardized classification with provisional clinical applications. Hum Pathol 1983;14:931–68.

    Article  PubMed  CAS  Google Scholar 

  87. Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152–7.

    Article  PubMed  CAS  Google Scholar 

  88. Dixon MF, Brown LJ, Gilmour HM, Price AB, Smeeton NC, Talbot IC, Williams GT. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385–97.

    Article  PubMed  CAS  Google Scholar 

  89. Melville DM, Jass JR, Morson BC, Pollock DJ, Richman PI, Shepherd NA, Ritchie JK, Love SB, Lennard-Jones JE. Observer study of the grading of dysplasia in ulcerative colitis:Comparison with clinical outcome. Hum Pathol 1989;20:1008–14.

    Article  PubMed  CAS  Google Scholar 

  90. Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, Lennard-Jones JE. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994;35:1419–23.

    Article  PubMed  CAS  Google Scholar 

  91. Ullman TA, Loftus EV, Jr., Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002;97:922–7.

    Article  PubMed  Google Scholar 

  92. Brentnall T, Bronner M, Rubin C, Rabinovitch P, Kimmey M, Kowdley K, Edmond M, Haggitt R. Natural history and management of low-grade dysplasia in ulcerative colitis. Gastroenterology 1999;116:A382.

    Google Scholar 

  93. Befrits R, Ljung T, Jaramillo E, Rubio C. Low grade dysplasia in flat colonic mucosa in patients with extensive longstanding inflammatory bowel disease – a follow-up study. Gastroenterology 1999;116:A376.

    Google Scholar 

  94. Befrits R, Ljung T, Jaramillo E, Rubio C. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: A follow-up study. Dis Colon Rectum 2002;45:615–20.

    Article  PubMed  CAS  Google Scholar 

  95. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003;52:1127–32.

    Article  PubMed  CAS  Google Scholar 

  96. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, Dean PJ, Kimmey M, Perera DR, Rabinovitch PS. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611–20.

    PubMed  CAS  Google Scholar 

  97. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance. Gastrointest Endosc 2000;51:123–8.

    Article  PubMed  CAS  Google Scholar 

  98. Ullman T, White J, Harpaz N, Itzkowitz S. Assessment of Biopsy Practices in Colonoscopic Surveillance in Ulcerative Colitis. Gastroenterology 2001;120:A–446.

    Article  Google Scholar 

  99. Rubin PH, et al. Colonoscopic polypectomy in chronic colitis:Conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999;117:1295–300.

    Article  PubMed  CAS  Google Scholar 

  100. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis [see comments]. Gastroenterology 1999;117:1288–94; discussion 1488–91.

    Article  PubMed  CAS  Google Scholar 

  101. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004;2:534–41.

    Article  PubMed  Google Scholar 

  102. Vieth M, Behrens H, Stolte M. Sporadic adenoma in ulcerative colitis: Endoscopic resection is an adequate treatment. Gut 2006;55:1151–5.

    Article  PubMed  CAS  Google Scholar 

  103. Selaru FM, Xu Y, Yin J, Zou T, Liu TC, Mori Y, Abraham JM, Sato F, Wang S, Twigg C, Olaru A, Shustova V, Leytin A, Hytiroglou P, Shibata D, Harpaz N, Meltzer SJ. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastro 2002;122:606–613.

    Article  Google Scholar 

  104. Bernstein CN, Weinstein WM, Levine DS, Shanahan F. Physicians’ perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995;90:2106–14.

    PubMed  CAS  Google Scholar 

  105. Rubin DT, Turner JR. Surveillance of dysplasia in inflammatory bowel disease:The gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol 2006;4:1309–13.

    Article  PubMed  Google Scholar 

  106. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314–21.

    Article  PubMed  Google Scholar 

  107. Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S, Nafe B, Jung M, Galle PR, Neurath MF. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880–8.

    Article  PubMed  Google Scholar 

  108. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256–60.

    Article  PubMed  CAS  Google Scholar 

  109. Gollop JH, Phillips SF, Melton LJ, 3rd, Zinsmeister AR. Epidemiologic aspects of Crohn disease: A population based study in Olmsted County, Minnesota, 1943–1982. Gut 1988;29:49–56.

    Article  PubMed  CAS  Google Scholar 

  110. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn disease. Gastroenterology 1993;105:1716–23.

    PubMed  CAS  Google Scholar 

  111. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF. Crohn disease and cancer. N Engl J Med 1973;289:1099–103.

    Article  PubMed  CAS  Google Scholar 

  112. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH, Jr. A comparison of cancer risk in Crohn disease and ulcerative colitis. Cancer 1981;48:2742–5.

    Article  PubMed  CAS  Google Scholar 

  113. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn disease: A comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590–2.

    Article  PubMed  CAS  Google Scholar 

  114. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn disease with colonic involvement. Lancet 1990;336:357–9.

    Article  PubMed  CAS  Google Scholar 

  115. Sachar DB. Cancer in Crohn disease: Dispelling the myths. Gut 1994;35:1507–8.

    Article  PubMed  CAS  Google Scholar 

  116. Ekbom A, Helmick C, Zack M, Adami HO. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991;67:2015–9.

    Article  PubMed  CAS  Google Scholar 

  117. Canavan C, Abrams KR, Mayberry J. Meta-analysis: Colorectal and small bowel cancer risk in patients with Crohn disease. Aliment Pharmacol Ther 2006;23:1097–104.

    Article  PubMed  CAS  Google Scholar 

  118. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn disease and ulcerative colitis: Implications for carcinogenesis and prevention. Gut 1994;35:950–4.

    Article  PubMed  CAS  Google Scholar 

  119. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn colitis. Gastroenterology 2001;120:820–6.

    Article  PubMed  CAS  Google Scholar 

  120. Greenstein AJ, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, Aufses AH, Jr. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985;56:2914–21.

    Article  PubMed  CAS  Google Scholar 

  121. Mir Madjlessi SH, Farmer RG, Weick JK. Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn disease and review of the literature. Dig Dis Sci 1986;31:1025–31.

    Article  PubMed  CAS  Google Scholar 

  122. Cuttner J. Increased incidence of acute promyelocytic leukemia in patients with ulcerative colitis. Ann Intern Med 1982;97:864–5.

    PubMed  CAS  Google Scholar 

  123. Persson PG, Karlen P, Bernell O, Leijonmarck CE, Brostrom O, Ahlbom A, Hellers G. Crohn disease and cancer: A population-based cohort study. Gastroenterology 1994;107:1675–9.

    PubMed  CAS  Google Scholar 

  124. Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Corry RJ. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989;47:293–6.

    Article  PubMed  CAS  Google Scholar 

  125. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514–6.

    Article  PubMed  CAS  Google Scholar 

  126. Silman AJ, Petrie J, Hazleman B, Evans SJ. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: A 20 year follow up study. Ann Rheum Dis 1988;47:988–92.

    Article  PubMed  CAS  Google Scholar 

  127. Loftus EV, Jr., Tremaine WJ, Habermann TM, Harmsen WS, Zinsmeister AR, Sandborn WJ. Risk of lymphoma in inflammatory bowel disease. AmJ Gastroenterol 2000;95:2308–12.

    Article  Google Scholar 

  128. Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999;94:3248–53.

    Article  PubMed  CAS  Google Scholar 

  129. Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;44:265–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Assistant Professor of Medicine, The Dr. Henry D. Janowitz Division of Gastroenterology, The Mount S School of Medicine, NY, New York, USA

    Thomas A. Ullman M.D.

Authors
  1. Thomas A. Ullman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Attending Physician, Division of GI Hepatology and Nutrition, Director Endoscopy Suite, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Petar Mamula M.D. (Assistant Professor of Pediatrics) (Assistant Professor of Pediatrics)

  2. Attending Physician, Children’s Center for Digestive Health, Greenville Hospital System University Medical Center, University of South Carolina School of Medicine, Greenville, South Carolina, USA

    Jonathan E. Markowitz M.D., M.S.C.E. (Associate Professor of Clinical Pediatrics) (Associate Professor of Clinical Pediatrics)

  3. Attending Physician and Director, Inflammatory Bowel Disease Center Division of GI, Hepatology and Nutrition. The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Robert N. Baldassano M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ullman, T.A. (2008). Malignant Tumors Arising in Inflammatory Bowel Disease. In: Mamula, P., Markowitz, J.E., Baldassano, R.N. (eds) Pediatric Inflammatory Bowel Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73481-1_46

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-73481-1_46

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-73480-4

  • Online ISBN: 978-0-387-73481-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation